About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
GLMD
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Galmed Pharmaceuticals announces receipt of Nasdaq minimum bid price notification
- Drugmakers still chasing potentially lucrative NASH market, despite setbacks
- Galmed shares slump on pricing discounted stock and warrants offering
- Galmed rises 17% on positive data from NASH treatment trial
- Galmed Pharmaceuticals gets an extension from Nasdaq to regain compliance
- Galmed GAAP EPS of -$0.15 beats by $0.09
- Galmed Pharma receives non-compliance letter from Nasdaq
- Galmed Pharmaceuticals shares fall after downgrade by Raymond James analyst
- Galmed GAAP EPS of -$0.24 beats by $0.08
- Galmed slips further as H.C. Wainwright cuts rating on uncertainty to NASH trial
- Galmed GAAP EPS of -$0.30 in-line
- Galmed gains 5% after securing three new U.S. patents for Aramchol and meglumine salt
- Galmed EPS beats by $0.05
- Galmed posts initial results from late-stage Aramchol NASH and liver fibrosis trial
- Galmed EPS beats by $0.05
- Exicure, Infinity Pharmaceuticals leads healthcare gainers; TG Therapeutics, Immunovant among major losers
- Galmed Pharma jumps 8% on FDA green light to use Aramchol Meglumine in late-stage ARMOR study
- Galmed EPS beats by $0.01
- Galmed gets greenlight for late-stage Aramchol NASH trial in China
- Galmed EPS misses by $0.11
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 | 1.490 | 1.440 |
1.500
|
1.360
|
53.17K | 9.96% | ||||
| Mar 16 | 1.355 | 1.298 |
1.396
|
1.298
|
42.53K | 10.16% | ||||
| Mar 15 | 1.230 | 1.230 |
1.320
|
1.190
|
202.99K | -4.65% | ||||
| Mar 14 | 1.290 | 1.350 |
1.370
|
1.250
|
55.89K | -4.44% | ||||
| Mar 11 | 1.350 | 1.380 |
1.400
|
1.300
|
88.58K | -2.88% | ||||
| Mar 10 | 1.390 | 1.420 |
1.425
|
1.360
|
45.79K | -0.71% | ||||
| Mar 9 | 1.400 | 1.340 |
1.460
|
1.340
|
77.89K | 3.70% | ||||
| Mar 8 | 1.350 | 1.320 |
1.350
|
1.280
|
84.57K | 0.75% | ||||
| Mar 7 | 1.340 | 1.320 |
1.380
|
1.320
|
41.65K | 0% | ||||
| Mar 4 | 1.340 | 1.480 |
1.480
|
1.340
|
127.46K | -10.07% | ||||
| Mar 3 | 1.490 | 1.630 |
1.630
|
1.470
|
76.11K | -9.7% | ||||
| Mar 2 | 1.650 | 1.490 |
1.660
|
1.470
|
273.82K | 12.24% | ||||
| Mar 1 | 1.470 | 1.460 |
1.497
|
1.460
|
13.02K | 2.08% | ||||
| Feb 28 | 1.440 | 1.460 |
1.540
|
1.440
|
64.62K | -7.09% | ||||
| Feb 25 | 1.550 | 1.520 |
1.600
|
1.490
|
21.26K | 1.97% | ||||
| Feb 24 | 1.520 | 1.400 |
1.552
|
1.350
|
86.70K | 4.83% | ||||
| Feb 23 | 1.450 | 1.530 |
1.612
|
1.400
|
57.13K | -4.61% | ||||
| Feb 22 | 1.520 | 1.540 |
1.610
|
1.460
|
160.40K | -6.75% | ||||
| Feb 18 | 1.630 | 1.570 |
1.630
|
1.530
|
26.75K | 2.52% | ||||